AC Immune SA (ACIU)
USD 2.77
(-5.78%)
USD 2.77
(-5.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -74.99 Million CHF | -160.54% |
| 2022 | -28.78 Million CHF | 63.7% |
| 2021 | -79.3 Million CHF | 50.02% |
| 2020 | -158.67 Million CHF | 16.79% |
| 2019 | -190.68 Million CHF | -22.27% |
| 2018 | -155.94 Million CHF | -25.78% |
| 2017 | -123.98 Million CHF | 18.55% |
| 2016 | -152.21 Million CHF | -98.91% |
| 2015 | -76.52 Million CHF | -2214.64% |
| 2014 | -3.3 Million CHF | 70.62% |
| 2013 | -11.25 Million CHF | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -48.33 Million CHF | 9.96% |
| 2024 Q1 | -53.68 Million CHF | 28.42% |
| 2023 Q3 | -29.53 Million CHF | 21.2% |
| 2023 Q4 | -74.99 Million CHF | -153.93% |
| 2023 FY | -74.99 Million CHF | -160.54% |
| 2023 Q1 | -54.76 Million CHF | -90.27% |
| 2023 Q2 | -37.47 Million CHF | 31.57% |
| 2022 Q3 | -42.01 Million CHF | 30.57% |
| 2022 Q2 | -60.52 Million CHF | -9.9% |
| 2022 FY | -28.78 Million CHF | 63.7% |
| 2022 Q1 | -55.06 Million CHF | 30.57% |
| 2022 Q4 | -28.78 Million CHF | 31.5% |
| 2021 Q2 | -101.43 Million CHF | 31.9% |
| 2021 Q4 | -79.3 Million CHF | 12.86% |
| 2021 FY | -79.3 Million CHF | 50.02% |
| 2021 Q1 | -148.94 Million CHF | 6.13% |
| 2021 Q3 | -91.01 Million CHF | 10.28% |
| 2020 Q2 | -175.1 Million CHF | 2.93% |
| 2020 Q3 | -174.32 Million CHF | 0.44% |
| 2020 Q4 | -158.67 Million CHF | 8.98% |
| 2020 FY | -158.67 Million CHF | 16.79% |
| 2020 Q1 | -180.38 Million CHF | 5.4% |
| 2019 Q4 | -190.68 Million CHF | 9.17% |
| 2019 FY | -190.68 Million CHF | -22.27% |
| 2019 Q3 | -209.93 Million CHF | -3.33% |
| 2019 Q2 | -203.17 Million CHF | -17.64% |
| 2019 Q1 | -172.71 Million CHF | -10.75% |
| 2018 Q4 | -155.94 Million CHF | 21.45% |
| 2018 Q3 | -198.53 Million CHF | -94.43% |
| 2018 Q2 | -102.11 Million CHF | 6.52% |
| 2018 Q1 | -109.23 Million CHF | 11.9% |
| 2018 FY | -155.94 Million CHF | -25.78% |
| 2017 Q2 | -123.79 Million CHF | 10.35% |
| 2017 Q3 | -116.81 Million CHF | 5.64% |
| 2017 Q4 | -123.98 Million CHF | -6.13% |
| 2017 FY | -123.98 Million CHF | 18.55% |
| 2017 Q1 | -138.08 Million CHF | 9.28% |
| 2016 Q4 | -152.21 Million CHF | 3.42% |
| 2016 Q3 | -157.59 Million CHF | -91.31% |
| 2016 Q2 | -82.37 Million CHF | -21.39% |
| 2016 Q1 | -67.86 Million CHF | 11.32% |
| 2016 FY | -152.21 Million CHF | -98.91% |
| 2015 FY | -76.52 Million CHF | -2214.64% |
| 2015 Q4 | -76.52 Million CHF | -42.54% |
| 2015 Q3 | -53.68 Million CHF | -177.37% |
| 2015 Q2 | -19.35 Million CHF | -685.45% |
| 2015 Q1 | 3.3 Million CHF | 200.0% |
| 2014 Q4 | -3.3 Million CHF | 0.0% |
| 2014 FY | -3.3 Million CHF | 70.62% |
| 2013 FY | -11.25 Million CHF | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1075.686% |
| Better Therapeutics, Inc. | -860 Thousand USD | -8620.581% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 10.825% |
| Nutriband Inc. | -251.65 Thousand USD | -29701.277% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 105.499% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 68.01% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 20.395% |
| BioAtla, Inc. | -109.01 Million USD | 31.202% |
| Genelux Corporation | -6.89 Million USD | -987.071% |
| ESSA Pharma Inc. | -33.62 Million USD | -123.062% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -237.338% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -143.008% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1176.294% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -2296.822% |
| Soligenix, Inc. | -4.95 Million USD | -1414.602% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -903.413% |
| Kura Oncology, Inc. | -20.11 Million USD | -272.786% |
| Dyadic International, Inc. | -6.37 Million USD | -1075.852% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -83.25% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -793.034% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 4216.88% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -2245.855% |
| Autolus Therapeutics plc | -186.59 Million USD | 59.808% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -370.702% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 72.807% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 145.627% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -734.873% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -125.507% |
| IGM Biosciences, Inc. | -72.6 Million USD | -3.293% |
| INmune Bio, Inc. | -25.41 Million USD | -195.136% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 149.683% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -146.215% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -48.043% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -2499.616% |
| Opthea Limited | 28.15 Million USD | 366.349% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -82.098% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 335.211% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -726.595% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -44.609% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -346.703% |
| NextCure, Inc. | -6.47 Million USD | -1057.897% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -777.859% |
| Surrozen, Inc. | -32.66 Million USD | -129.601% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1684.161% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 495.549% |
| Organovo Holdings, Inc. | -1.5 Million USD | -4876.576% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 167.644% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -72.637% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 76.326% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 3.168% |
| PureTech Health plc | -167.19 Million USD | 55.145% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -395.52% |
| Mesoblast Limited | 55.96 Million USD | 234.012% |
| Turnstone Biologics Corp. | -14.58 Million USD | -414.242% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 41.914% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -196.525% |
| Synaptogenix, Inc. | -28.66 Million USD | -161.665% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -7912.5% |
| ChromaDex Corporation | -24.04 Million USD | -211.864% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -932.152% |
| Exelixis, Inc. | -73.05 Million USD | -2.665% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 222.43% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 68.929% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -956.296% |
| Seer, Inc. | -4.24 Million USD | -1668.797% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 6080.622% |
| Gritstone bio, Inc. | 39.49 Million USD | 289.914% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -2749.279% |
| Avid Bioservices, Inc. | 169.72 Million USD | 144.187% |
| Insmed Incorporated | 721.62 Million USD | 110.393% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 221.618% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -887.322% |
| MediWound Ltd. | -5.32 Million USD | -1309.188% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 307.386% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1078.434% |
| OmniAb, Inc. | 9.2 Million USD | 914.919% |
| Alector, Inc. | -35.63 Million USD | -110.447% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 187.235% |
| Zai Lab Limited | -775 Million USD | 90.323% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 122.022% |
| Immunic, Inc. | -45.34 Million USD | -65.41% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 61.185% |
| Veracyte, Inc. | -203.82 Million USD | 63.205% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 111.75% |
| FibroGen, Inc. | 56.76 Million USD | 232.114% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 942.19% |
| ContextLogic Inc. | -232 Million USD | 67.674% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 69.056% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -2552.806% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 32.152% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 101.634% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -2144.747% |
| ImmuCell Corporation | 10.99 Million USD | 782.376% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 104.779% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -206.46% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 10.825% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -112.679% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1417.818% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 55.992% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 18.812% |
| Vaxxinity, Inc. | 10.13 Million USD | 840.199% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 110.186% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -596.509% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -2072.143% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -396.293% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -176.742% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 1852.266% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -3136.777% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -84.849% |
| Ardelyx, Inc. | 34.51 Million USD | 317.307% |
| Pluri Inc. | 22.82 Million USD | 428.516% |
| Prothena Corporation plc | -608.34 Million USD | 87.672% |
| Celularity Inc. | 65.19 Million USD | 215.044% |
| Rallybio Corporation | -24.1 Million USD | -211.165% |
| Cue Biopharma, Inc. | -33.81 Million USD | -121.76% |
| MeiraGTx Holdings plc | -40.3 Million USD | -86.088% |
| Omeros Corporation | 331.17 Million USD | 122.646% |
| Humacyte, Inc. | -22.48 Million USD | -233.528% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -205.176% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -142.701% |
| Blueprint Medicines Corporation | 702.83 Million USD | 110.671% |
| IO Biotech, Inc. | -140.69 Million USD | 46.697% |
| Aptose Biosciences Inc. | -8.19 Million USD | -815.172% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 481.761% |
| Century Therapeutics, Inc. | 847 Thousand USD | 8954.427% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 318.854% |
| CalciMedica, Inc. | -5.53 Million USD | -1256.184% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 60.155% |
| Precision BioSciences, Inc. | -85.41 Million USD | 12.192% |
| Summit Therapeutics Inc. | 34.67 Million USD | 316.292% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1137.166% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -87.319% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 51.347% |
| GRI Bio, Inc. | -1.79 Million USD | -4080.435% |
| Pulmatrix, Inc. | -10.41 Million USD | -619.948% |
| Cingulate Inc. | 3.08 Million USD | 2532.848% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 32.679% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -25.112% |
| Cytokinetics, Incorporated | 642.37 Million USD | 111.675% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -1187.944% |
| Acelyrin, Inc. | -216.9 Million USD | 65.424% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -414.494% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -119.81% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -911.286% |
| Vor Biopharma Inc. | 4.3 Million USD | 1844.116% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.757% |
| Evogene Ltd. | -19.63 Million USD | -281.975% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -212.318% |
| ProKidney Corp. | -56.23 Million USD | -33.361% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -54.087% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -711.903% |
| CorMedix Inc. | -43.05 Million USD | -74.199% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 2966.858% |
| BioLineRx Ltd. | 7.33 Million USD | 1122.315% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -173.064% |
| Atai Life Sciences N.V. | -28.55 Million USD | -162.613% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -228.704% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 35.925% |
| MediciNova, Inc. | -50.78 Million USD | -47.68% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -333294.088% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1062.278% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 62.468% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 58.096% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 1904.548% |
| Senti Biosciences, Inc. | 1.74 Million USD | 4410.172% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -10286.533% |
| Apollomics, Inc. | -27.39 Million USD | -173.762% |
| 89bio, Inc. | -289.05 Million USD | 74.054% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 20.926% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 74.47% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1742.51% |
| Ainos, Inc. | 4.07 Million USD | 1939.096% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 21.63% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -91.941% |
| Allakos Inc. | -24.97 Million USD | -200.288% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -408.73% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 44.611% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 10288.896% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -7886.901% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 726.751% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -253.709% |
| Precigen, Inc. | -481 Thousand USD | -15491.892% |
| XOMA Corporation | -29 Million USD | -158.61% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -352.88% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 253.897% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 4.832% |
| Incyte Corporation | -3.17 Billion USD | 97.638% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -99452.659% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -731.821% |
| MiMedx Group, Inc. | -33.9 Million USD | -121.224% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 39.827% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -304.955% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -361.538% |
| CRISPR Therapeutics AG | -150.84 Million USD | 50.282% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 63.972% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -8599.45% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 19.152% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -8628.864% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -27.383% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -6212.161% |
| UroGen Pharma Ltd. | 4.39 Million USD | 1807.971% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 166.088% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 104317.504% |
| Entera Bio Ltd. | -10.62 Million USD | -605.588% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -908.277% |
| Generation Bio Co. | 31.44 Million USD | 338.479% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 146.368% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -236.49% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 59.375% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -52.111% |
| Novavax, Inc. | -298.29 Million USD | 74.858% |
| Chimerix, Inc. | -25.51 Million USD | -193.91% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -181.32% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -720.4% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 716.586% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -3707.318% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1421.855% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 666.485% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -735.523% |
| Histogen Inc. | -7.48 Million USD | -901.696% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -247.099% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -6212.161% |
| Portage Biotech Inc. | -4.98 Million USD | -1405.662% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -333294.088% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 9.073% |
| OncoCyte Corporation | -6.56 Million USD | -1042.724% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 8457.022% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -794.829% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -1546.244% |
| Purple Biotech Ltd. | -14.13 Million USD | -430.464% |
| PDS Biotechnology Corporation | -32.7 Million USD | -129.286% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 54.811% |
| Amarin Corporation plc | -191.04 Million USD | 60.743% |
| TG Therapeutics, Inc. | 17.86 Million USD | 519.869% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -349.295% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -551.751% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 79.665% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 10288.896% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 2.876% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -2161.026% |
| Savara Inc. | 153 Thousand USD | 49117.647% |
| Curis, Inc. | -23.88 Million USD | -213.966% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -13.708% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1354.019% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -9564.412% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1108.07% |
| Bicycle Therapeutics plc | -481.46 Million USD | 84.423% |
| BeiGene, Ltd. | -2.25 Billion USD | 96.671% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 707.829% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 59.589% |
| Erasca, Inc. | -37.21 Million USD | -101.518% |
| Aura Biosciences, Inc. | -21.52 Million USD | -248.418% |
| bluebird bio, Inc. | 108.57 Million USD | 169.076% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -5723.232% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -331.116% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 119.801% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -3522.434% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1078.434% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 57.201% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -60102.288% |
| Galecto, Inc. | -21.21 Million USD | -253.493% |
| XBiotech Inc. | -200.02 Million USD | 62.506% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 1756.294% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 36.848% |
| Molecular Templates, Inc. | 707 Thousand USD | 10707.779% |
| NexImmune, Inc. | -3.13 Million USD | -2293.285% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 119.843% |
| Verastem, Inc. | -37.27 Million USD | -101.183% |
| Imunon, Inc. | -4.21 Million USD | -1679.773% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -132.39% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -118.167% |
| Onconetix, Inc. | 5.33 Million USD | 1506.694% |
| MacroGenics, Inc. | -66.98 Million USD | -11.961% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -48.506% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 121.637% |
| GT Biopharma, Inc. | -1.02 Million USD | -7245.446% |
| Adagene Inc. | -87.62 Million USD | 14.414% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -634.257% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -10.643% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -125.535% |
| Annexon, Inc. | -193.75 Million USD | 61.293% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -54.604% |
| SciSparc Ltd. | -2.06 Million USD | -3531.816% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1154.76% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -96.626% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -525.408% |
| Minerva Neurosciences, Inc. | 41 Million USD | 282.901% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 57.234% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -142.528% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 164.324% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 16.919% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -3027.888% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 104.011% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1187.765% |
| Immunocore Holdings plc | -358.59 Million USD | 79.086% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -998.857% |
| 2seventy bio, Inc. | 181.71 Million USD | 141.272% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 262.518% |
| ADMA Biologics, Inc. | 90.06 Million USD | 183.269% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 3462.297% |
| Clene Inc. | 3.34 Million USD | 2345.419% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 522.876% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 0.103% |
| Biomea Fusion, Inc. | -166.57 Million USD | 54.976% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -725.712% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -248.645% |
| Mereo BioPharma Group plc | -51.46 Million USD | -45.713% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -188.454% |
| Absci Corporation | -72.59 Million USD | -3.304% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -215.312% |
| aTyr Pharma, Inc. | -7.44 Million USD | -906.806% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1339.758% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 4721.2% |
| Trevena, Inc. | 2.25 Million USD | 3421.391% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 105.431% |
| Akari Therapeutics, Plc | -3.84 Million USD | -1850.507% |
| Acasti Pharma Inc. | -23 Million USD | -226.003% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -216.75% |
| Orgenesis Inc. | 21.78 Million USD | 444.276% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 18.242% |
| GH Research PLC | -78.07 Million USD | 3.945% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -45.597% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -2453.524% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1143.509% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -707.181% |
| Jaguar Health, Inc. | 29.39 Million USD | 355.17% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 632.611% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -1732.965% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 5.454% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 42.947% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 28.941% |
| Clearmind Medicine Inc. | -3.94 Million USD | -1802.204% |
| Xencor, Inc. | 29.64 Million USD | 352.992% |
| Replimune Group, Inc. | 1.41 Million USD | 5411.402% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -30522.519% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 40.675% |
| Kronos Bio, Inc. | -36.05 Million USD | -108.013% |
| Innoviva, Inc. | 255.56 Million USD | 129.346% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 897.077% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 12042.197% |
| MEI Pharma, Inc. | -3.7 Million USD | -1924.211% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 5243.379% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -13.422% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -38.228% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -215.697% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1045.867% |
| HilleVax, Inc. | -165.48 Million USD | 54.68% |
| Statera Biopharma, Inc. | 14.41 Million USD | 620.22% |
| ImmunityBio, Inc. | 618.22 Million USD | 112.131% |
| Tharimmune, Inc. | -10.93 Million USD | -585.822% |
| Korro Bio, Inc. | -132.94 Million USD | 43.587% |
| Genprex, Inc. | -6.73 Million USD | -1013.107% |
| AlloVir, Inc. | -62.69 Million USD | -19.628% |
| Kineta, Inc. | -4.54 Million USD | -1551.553% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 15.219% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 44.065% |
| Aptorum Group Limited | 1.35 Million USD | 5626.489% |
| OKYO Pharma Limited | -826.84 Thousand USD | -8970.228% |
| Codexis, Inc. | -43.27 Million USD | -73.319% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 76.319% |
| Celularity Inc. | 65.19 Million USD | 215.044% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -2266.583% |
| Agenus Inc. | 274.13 Million USD | 127.358% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 6428.861% |
| Cibus, Inc. | -8.07 Million USD | -828.41% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -34.853% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -1673.398% |
| Kodiak Sciences Inc. | -103.87 Million USD | 27.801% |
| DBV Technologies S.A. | -126.98 Million USD | 40.941% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 208425.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -328.579% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -2034.842% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -5723.232% |
| Moderna, Inc. | -2.9 Billion USD | 97.42% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 107.114% |
| Peak Bio, Inc. | 10.34 Million USD | 825.298% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -624.469% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -590.072% |
| Eyenovia, Inc. | 1.25 Million USD | 6058.281% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1002.411% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -159.757% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 378.747% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -139.065% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 8.609% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 55.421% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2212.581% |
| Alkermes plc | -166.73 Million USD | 55.021% |
| Arcellx, Inc. | -296.95 Million USD | 74.745% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -284.482% |
| Adicet Bio, Inc. | -138.78 Million USD | 45.963% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -261.832% |
| Moolec Science SA | 117.61 Thousand USD | 63864.284% |
| Prime Medicine, Inc. | -27.94 Million USD | -168.412% |
| Aditxt, Inc. | 18.12 Million USD | 513.871% |
| RenovoRx, Inc. | -1.17 Million USD | -6293.606% |
| Geron Corporation | 14.76 Million USD | 608.075% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -97.787% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -212.006% |
| Royalty Pharma plc | 5.65 Billion USD | 101.325% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1700.463% |
| Quantum-Si incorporated | -118.55 Million USD | 36.742% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 46.969% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -973.007% |
| GlycoMimetics, Inc. | -40.98 Million USD | -82.989% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1298.452% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 46.709% |
| Humacyte, Inc. | -22.48 Million USD | -233.528% |
| Structure Therapeutics Inc. | -124.33 Million USD | 39.683% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -141.466% |
| Notable Labs, Ltd. | -9.77 Million USD | -667.154% |
| Liquidia Corporation | -80.17 Million USD | 6.46% |
| Mustang Bio, Inc. | -3.73 Million USD | -1907.414% |
| Immunovant, Inc. | -635.22 Million USD | 88.194% |
| Vericel Corporation | 1.27 Million USD | 5972.905% |
| Invivyd, Inc. | -198.47 Million USD | 62.214% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -326.993% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -1710.21% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1034.309% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -2127.262% |
| Vaxcyte, Inc. | -368.22 Million USD | 79.633% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 369.841% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -303.883% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 55.696% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 78.206% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 142.212% |
| PepGen Inc. | -60.67 Million USD | -23.615% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -226.415% |
| United Therapeutics Corporation | -507.7 Million USD | 85.228% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 1599.34% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -8599.45% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1684.161% |
| Silo Pharma, Inc. | -3.52 Million USD | -2027.992% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 75270.644% |
| Belite Bio, Inc | -87.27 Million USD | 14.064% |
| Pharming Group N.V. | 109.8 Million USD | 168.301% |
| XOMA Corporation | -29 Million USD | -158.61% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -5.943% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -304.955% |
| Bionomics Limited | 227 Million USD | 133.037% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 35.504% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 835.625% |
| Cassava Sciences, Inc. | -121.13 Million USD | 38.089% |
| AbCellera Biologics Inc. | -55.94 Million USD | -34.067% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1700.463% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 33.376% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 699.448% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1062.278% |
| Surrozen, Inc. | -32.66 Million USD | -129.601% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1505.228% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 70851.887% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 42.445% |
| Evaxion Biotech A/S | 5.28 Million USD | 1518.559% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 942.19% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 42.869% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 137.865% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1236.781% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -2860.797% |
| BioVie Inc. | -17.73 Million USD | -322.939% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -4250.174% |
| Compugen Ltd. | -12.9 Million USD | -481.192% |
| Virax Biolabs Group Limited | -3.36 Million USD | -2128.774% |
| Lantern Pharma Inc. | -21.7 Million USD | -245.556% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 8.293% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 1741.072% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -26400.707% |
| Benitec Biopharma Inc. | -50.58 Million USD | -48.268% |
| Immix Biopharma, Inc. | -17.5 Million USD | -328.315% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 28.121% |
| Celcuity Inc. | 6.78 Million USD | 1205.578% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 534.061% |
| PolyPid Ltd. | 6.17 Million USD | 1315.511% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -95.31% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 201.183% |
| IN8bio, Inc. | -16.38 Million USD | -357.606% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -4106.225% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 189.71% |
| Instil Bio, Inc. | 75.35 Million USD | 199.521% |
| Quantum-Si incorporated | -118.55 Million USD | 36.742% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -361.538% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 45.552% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1179.812% |
| Solid Biosciences Inc. | -47.75 Million USD | -57.062% |
| Immuneering Corporation | -54.94 Million USD | -36.5% |
| Verona Pharma plc | -220.44 Million USD | 65.979% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -2860.797% |
| uniQure N.V. | -102.95 Million USD | 27.153% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -125.575% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 283.138% |
| Shattuck Labs, Inc. | -121.42 Million USD | 38.235% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -197.112% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -1615.001% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 43.072% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -2306.556% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -292.121% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -6.082% |
| Zura Bio Limited | -99.8 Million USD | 24.857% |
| Forte Biosciences, Inc. | -11.96 Million USD | -527.013% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -3177.874% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -441.26% |
| Elevation Oncology, Inc. | -19.11 Million USD | -292.285% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2212.581% |
| Immunome, Inc. | -97.02 Million USD | 22.707% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -233.394% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -4.536% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 59.57% |
| Altimmune, Inc. | -134.48 Million USD | 44.235% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 297.283% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -34.249% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 571.727% |
| Moolec Science SA | 117.61 Thousand USD | 63864.284% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -2323.793% |
| Lumos Pharma, Inc. | -28.49 Million USD | -163.212% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -4.536% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -11337.177% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 481.761% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -261.017% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 5243.379% |
| Nutriband Inc. | -251.65 Thousand USD | -29701.277% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -908.024% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -5253.105% |
| argenx SE | -2.02 Billion USD | 96.303% |
| Neurogene Inc. | -131.95 Million USD | 43.165% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 46.549% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 443.771% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1427.745% |
| NeurAxis, Inc. | 145.7 Thousand USD | 51573.576% |
| CervoMed Inc. | -7.79 Million USD | -862.383% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 80.117% |
| Sesen Bio, Inc. | -112.55 Million USD | 33.367% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 308.296% |
| AnaptysBio, Inc. | -18.15 Million USD | -313.184% |
| Design Therapeutics, Inc. | -18.15 Million USD | -313.207% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -6.559% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 767.708% |
| Achilles Therapeutics plc | -126.92 Million USD | 40.912% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -2854.965% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -469.41% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 122.045% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 415.976% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 83.24% |
| Palisade Bio, Inc. | -12.06 Million USD | -521.711% |
| Beam Therapeutics Inc. | -262.72 Million USD | 71.454% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1436.824% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 24.898% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -3094.362% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -92.172% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 9.948% |
| Athira Pharma, Inc. | -88.99 Million USD | 15.733% |
| Vaccinex, Inc. | -1.28 Million USD | -5722.748% |
| HCW Biologics Inc. | 2.85 Million USD | 2725.324% |
| XOMA Corporation | -29 Million USD | -158.61% |
| Nektar Therapeutics | 210.24 Million USD | 135.672% |
| Arvinas, Inc. | -313.8 Million USD | 76.1% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 4721.2% |
| Merus N.V. | -192.88 Million USD | 61.118% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 225.026% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -980.96% |
| Rezolute, Inc. | -68.16 Million USD | -10.018% |
| Clene Inc. | 3.34 Million USD | 2345.419% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -468.719% |
| BeyondSpring Inc. | -13.75 Million USD | -445.234% |
| Synlogic, Inc. | -6.68 Million USD | -1021.87% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 6713.492% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -787.014% |
| Peak Bio, Inc. | 10.34 Million USD | 825.298% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 9.006% |
| Krystal Biotech, Inc. | -350.23 Million USD | 78.587% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 160.421% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 55.622% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -2275.47% |
| MannKind Corporation | 143.89 Million USD | 152.118% |
| Ikena Oncology, Inc. | -109.15 Million USD | 31.294% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -890.582% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -126.577% |
| Gossamer Bio, Inc. | 180.35 Million USD | 141.583% |
| CohBar, Inc. | -5.93 Million USD | -1164.549% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -152.108% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1742.51% |
| Legend Biotech Corporation | -949.39 Million USD | 92.101% |
| Mural Oncology plc | -255.84 Million USD | 70.686% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 332.801% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -1492.076% |
| Disc Medicine, Inc. | -358.28 Million USD | 79.068% |
| Champions Oncology, Inc. | 4.81 Million USD | 1658.541% |
| REGENXBIO Inc. | 54.76 Million USD | 236.936% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -27789.568% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 50.341% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -732.19% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 7.047% |
| Vaxart, Inc. | -8.24 Million USD | -810.047% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -49.456% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 41.024% |
| Cellectis S.A. | -43.85 Million USD | -71.011% |
| Longeveron Inc. | -2.9 Million USD | -2478.989% |
| Repare Therapeutics Inc. | -107.85 Million USD | 30.467% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 107.745% |
| Inozyme Pharma, Inc. | 12 Million USD | 724.767% |
| Revolution Medicines, Inc. | -608.2 Million USD | 87.669% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -5997.317% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 71.712% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 50.026% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -379.306% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -10034.73% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 99.216% |
| Denali Therapeutics Inc. | -74.86 Million USD | -0.176% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -525.408% |
| Veru Inc. | 4.77 Million USD | 1668.985% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -566.877% |
| Cingulate Inc. | 3.08 Million USD | 2532.848% |
| Passage Bio, Inc. | 4.58 Million USD | 1735.703% |
| Context Therapeutics Inc. | -14.44 Million USD | -419.017% |
| Exicure, Inc. | 5.84 Million USD | 1382.219% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 67.446% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -89.53% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 87.669% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 577.962% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -27.5% |
| Nuvalent, Inc. | -335.38 Million USD | 77.639% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 4424.236% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -0.691% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -743.611% |
| OmniAb, Inc. | 9.2 Million USD | 914.919% |
| Anew Medical, Inc. | 1.43 Million USD | 5335.521% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 557.808% |
| Lipocine Inc. | -4.75 Million USD | -1477.359% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 31.714% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 592.397% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -48.043% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 401.29% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1015.861% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -13.93% |
| Ocugen, Inc. | -32.52 Million USD | -130.611% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 12.361% |
| Q32 Bio Inc. | -37.94 Million USD | -97.631% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -11842.197% |
| Alumis Inc. Common Stock | -13.52 Million USD | -454.343% |
| Equillium, Inc. | -22.39 Million USD | -234.928% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -193.324% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -129.863% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -30151.094% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 155.95% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 2445.122% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 22934.238% |
| Dominari Holdings Inc. | 195 Thousand USD | 38560.0% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1323.928% |
| vTv Therapeutics Inc. | -8.91 Million USD | -741.056% |
| Bio-Techne Corporation | 267.74 Million USD | 128.01% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -362.687% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 36.494% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -792.503% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -492.815% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 69.404% |
| Nkarta, Inc. | 57.29 Million USD | 230.887% |
| BioCardia, Inc. | 212 Thousand USD | 35475.943% |
| Iterum Therapeutics plc | 13.43 Million USD | 658.096% |